Stanford

Irv Weissman

The Weissman lab studies the identification, isolation, and function of normal and cancer stem cells, including the lineage of their precursors and progeny, and the phylogeny of stem cells in colonial protochordates. We also are deeply involved in taking normal and cancer stem cell discoveries through preclinical proof of principle, and to and through early phase clinical trials in humans.The Weissman lab studies the identification, isolation, and function of normal and cancer stem cells, including the lineage of their precursors and progeny, and the phylogeny of stem cells in colonial protochordates. We also are deeply involved in taking normal and cancer stem cell discoveries through preclinical proof of principle, and to and through early phase clinical trials in humans.

Back to Top

News Releases

New antibody-combination therapy developed at Stanford boosts human lymphoma cure rate in mouse models

Melanoma-initiating cells identified by study

Back to Top

Recent Publications

Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma. Chao MP, Alizadeh AA, Tang C, Myklebust JH, Varghese B, Gill S, Jan M, Cha AC, Chan CK, Tan BT, Park CY, Zhao F, Kohrt HE, Malumbres R, Briones J, Gascoyne RD, Lossos IS, Levy R, Weissman IL, Majeti R. Cell. 2010; 142 (5): 699-713

Cancer stem cells in bladder cancer: a revisited and evolving concept. Chan KS, Volkmer JP, Weissman I. Curr Opin Urol. 2010; 20 (5): 393-7

Back to Top

Video

Back to Top

Contact Info

Institute for Stem Cell Biology & Regenerative Medicine
265 campus Dr.
Stanford, California 94305

Phone: (650) 723-6520

irv@stanford.edu

Back to Top